BAIT
APOA1
Alp-1, Apoa-1, Brp-14, Ltw-1, Lvtw-1, Sep-1, Sep-2, Sep2, apo-AI, apoA-I
apolipoprotein A-I
GO Process (53)
GO Function (19)
GO Component (14)
Gene Ontology Biological Process
- G-protein coupled receptor signaling pathway [ISO]
- adrenal gland development [IMP]
- axon regeneration [IGI]
- blood vessel endothelial cell migration [IMP]
- cholesterol biosynthetic process [IMP]
- cholesterol efflux [IDA, IMP, ISO]
- cholesterol homeostasis [IBA, ISO]
- cholesterol import [ISO]
- cholesterol metabolic process [IGI, IMP, ISO]
- cholesterol transport [IDA, IMP, ISO]
- endothelial cell proliferation [IMP]
- glucocorticoid metabolic process [IMP]
- high-density lipoprotein particle assembly [IBA, ISO]
- integrin-mediated signaling pathway [ISO]
- lipid storage [IMP]
- lipoprotein biosynthetic process [IGI, IMP]
- negative chemotaxis [ISO]
- negative regulation of cell adhesion molecule production [ISO]
- negative regulation of cytokine secretion involved in immune response [ISO]
- negative regulation of heterotypic cell-cell adhesion [ISO]
- negative regulation of hydrolase activity [IGI]
- negative regulation of inflammatory response [ISO]
- negative regulation of interleukin-1 beta secretion [ISO]
- negative regulation of lipase activity [ISO]
- negative regulation of response to cytokine stimulus [ISO]
- negative regulation of tumor necrosis factor-mediated signaling pathway [ISO]
- negative regulation of very-low-density lipoprotein particle remodeling [ISO]
- organ regeneration [ISO]
- peptidyl-methionine modification [ISO]
- phosphatidylcholine biosynthetic process [ISO]
- phosphatidylcholine metabolic process [IBA]
- phospholipid efflux [IBA, ISO]
- phospholipid homeostasis [ISO]
- phospholipid metabolic process [IMP]
- phospholipid transport [ISO]
- positive regulation of Rho protein signal transduction [ISO]
- positive regulation of cholesterol esterification [IBA, ISO]
- positive regulation of fatty acid biosynthetic process [IBA]
- positive regulation of hydrolase activity [ISO]
- positive regulation of lipoprotein lipase activity [IBA]
- positive regulation of stress fiber assembly [ISO]
- positive regulation of substrate adhesion-dependent cell spreading [ISO]
- positive regulation of transferase activity [IMP]
- positive regulation of triglyceride catabolic process [IBA]
- protein localization [IMP]
- protein oxidation [ISO]
- protein stabilization [ISO]
- regulation of Cdc42 protein signal transduction [ISO]
- regulation of intestinal cholesterol absorption [IDA]
- regulation of protein phosphorylation [IDA]
- reverse cholesterol transport [IBA, ISO]
- triglyceride homeostasis [IBA, ISO]
- very-low-density lipoprotein particle remodeling [IBA]
Gene Ontology Molecular Function- apolipoprotein A-I receptor binding [ISO]
- apolipoprotein receptor binding [ISO]
- beta-amyloid binding [ISO]
- chemorepellent activity [ISO]
- cholesterol binding [IBA, ISO]
- cholesterol transporter activity [IDA, ISO]
- enzyme binding [ISO]
- high-density lipoprotein particle binding [IDA]
- high-density lipoprotein particle receptor binding [IBA, ISO]
- identical protein binding [IPI, ISO]
- lipase inhibitor activity [ISO]
- lipid binding [IDA]
- lipid transporter activity [IDA, IMP]
- lipoprotein particle binding [IDA]
- phosphatidylcholine binding [IBA]
- phosphatidylcholine-sterol O-acyltransferase activator activity [IBA, ISO]
- phospholipid binding [ISO]
- phospholipid transporter activity [ISO]
- protein binding [IPI]
- apolipoprotein A-I receptor binding [ISO]
- apolipoprotein receptor binding [ISO]
- beta-amyloid binding [ISO]
- chemorepellent activity [ISO]
- cholesterol binding [IBA, ISO]
- cholesterol transporter activity [IDA, ISO]
- enzyme binding [ISO]
- high-density lipoprotein particle binding [IDA]
- high-density lipoprotein particle receptor binding [IBA, ISO]
- identical protein binding [IPI, ISO]
- lipase inhibitor activity [ISO]
- lipid binding [IDA]
- lipid transporter activity [IDA, IMP]
- lipoprotein particle binding [IDA]
- phosphatidylcholine binding [IBA]
- phosphatidylcholine-sterol O-acyltransferase activator activity [IBA, ISO]
- phospholipid binding [ISO]
- phospholipid transporter activity [ISO]
- protein binding [IPI]
Gene Ontology Cellular Component
- blood microparticle [IBA, ISO]
- cell surface [ISO]
- chylomicron [IBA]
- cytoplasmic vesicle [ISO]
- discoidal high-density lipoprotein particle [ISO]
- endocytic vesicle [ISO]
- extracellular region [IDA]
- extracellular space [IDA, ISO]
- extracellular vesicular exosome [ISO]
- high-density lipoprotein particle [IBA, ISO]
- nucleus [ISO]
- spherical high-density lipoprotein particle [ISO]
- very-low-density lipoprotein particle [ISO]
- vesicle [ISO]
Mus musculus
PREY
APOE
AI255918
apolipoprotein E
GO Process (84)
GO Function (19)
GO Component (28)
Gene Ontology Biological Process
- G-protein coupled receptor signaling pathway [ISO]
- N-methyl-D-aspartate receptor clustering [ISO]
- aging [ISO]
- alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering [ISO]
- artery morphogenesis [IGI]
- axon regeneration [IGI]
- cGMP-mediated signaling [ISO]
- cardiovascular system development [IMP]
- cellular calcium ion homeostasis [IDA]
- cholesterol biosynthetic process [IBA]
- cholesterol catabolic process [IMP]
- cholesterol efflux [IDA, IMP, ISO]
- cholesterol homeostasis [IGI, IMP, ISO]
- cholesterol metabolic process [IMP, ISO]
- chylomicron remnant clearance [ISO]
- fatty acid homeostasis [ISO]
- high-density lipoprotein particle assembly [IBA, ISO]
- high-density lipoprotein particle clearance [ISO]
- high-density lipoprotein particle remodeling [ISO]
- lipid homeostasis [IMP]
- lipid metabolic process [IGI]
- lipid transport [ISO]
- lipoprotein biosynthetic process [IGI]
- lipoprotein catabolic process [IMP]
- lipoprotein metabolic process [IGI, IMP, ISO]
- long-chain fatty acid transport [ISO]
- low-density lipoprotein particle remodeling [IMP]
- maintenance of location in cell [IMP]
- negative regulation of MAP kinase activity [ISO]
- negative regulation of beta-amyloid formation [ISO]
- negative regulation of blood coagulation [ISO]
- negative regulation of blood vessel endothelial cell migration [ISO]
- negative regulation of cholesterol biosynthetic process [ISO]
- negative regulation of cholesterol efflux [ISO]
- negative regulation of dendritic spine development [ISO]
- negative regulation of dendritic spine maintenance [ISO]
- negative regulation of endothelial cell proliferation [ISO]
- negative regulation of inflammatory response [IGI]
- negative regulation of lipid biosynthetic process [ISO]
- negative regulation of lipid transport across blood brain barrier [ISO]
- negative regulation of neuron apoptotic process [IBA, ISO]
- negative regulation of neuron death [ISO]
- negative regulation of phospholipid efflux [ISO]
- negative regulation of platelet activation [ISO]
- negative regulation of postsynaptic membrane organization [ISO]
- negative regulation of presynaptic membrane organization [ISO]
- nitric oxide mediated signal transduction [ISO]
- phospholipid efflux [IBA, ISO]
- positive regulation of axon extension [ISO]
- positive regulation of beta-amyloid formation [ISO]
- positive regulation of cGMP biosynthetic process [ISO]
- positive regulation of catalytic activity [IMP]
- positive regulation of cholesterol efflux [ISO]
- positive regulation of cholesterol esterification [IMP, ISO]
- positive regulation of dendritic spine development [ISO]
- positive regulation of dendritic spine maintenance [ISO]
- positive regulation of lipid biosynthetic process [IBA, ISO]
- positive regulation of lipid transport across blood brain barrier [ISO]
- positive regulation of low-density lipoprotein particle receptor catabolic process [ISO]
- positive regulation of membrane protein ectodomain proteolysis [ISO]
- positive regulation of neurofibrillary tangle assembly [ISO]
- positive regulation of neuron death [ISO]
- positive regulation of nitric-oxide synthase activity [IBA, ISO]
- positive regulation of phospholipid efflux [ISO]
- positive regulation of postsynaptic membrane organization [ISO]
- positive regulation of presynaptic membrane organization [ISO]
- protein import [ISO]
- protein localization [IMP]
- receptor-mediated endocytosis [ISO]
- regulation of Cdc42 protein signal transduction [ISO]
- regulation of axon extension [IBA]
- regulation of beta-amyloid clearance [IBA, ISO]
- regulation of cholesterol transport [IBA]
- regulation of gene expression [IMP]
- regulation of neuron death [ISO]
- regulation of tau-protein kinase activity [ISO]
- response to dietary excess [IMP]
- response to oxidative stress [IMP]
- reverse cholesterol transport [IBA, ISO]
- triglyceride catabolic process [IBA]
- triglyceride metabolic process [ISO]
- vasodilation [IMP]
- very-low-density lipoprotein particle clearance [ISO]
- very-low-density lipoprotein particle remodeling [IMP, ISO]
Gene Ontology Molecular Function- antioxidant activity [ISO]
- beta-amyloid binding [IBA, ISO]
- cholesterol binding [IBA]
- cholesterol transporter activity [IDA]
- heparin binding [ISO]
- hydroxyapatite binding [ISO]
- identical protein binding [ISO]
- lipid binding [ISO]
- lipid transporter activity [ISO]
- lipoprotein particle binding [IDA]
- low-density lipoprotein particle receptor binding [IBA, ISO]
- metal chelating activity [ISO]
- phosphatidylcholine-sterol O-acyltransferase activator activity [IMP, ISO]
- phospholipid binding [IBA, ISO]
- protein binding [IPI]
- protein homodimerization activity [ISO]
- receptor binding [ISO]
- tau protein binding [ISO]
- very-low-density lipoprotein particle receptor binding [IBA, ISO]
- antioxidant activity [ISO]
- beta-amyloid binding [IBA, ISO]
- cholesterol binding [IBA]
- cholesterol transporter activity [IDA]
- heparin binding [ISO]
- hydroxyapatite binding [ISO]
- identical protein binding [ISO]
- lipid binding [ISO]
- lipid transporter activity [ISO]
- lipoprotein particle binding [IDA]
- low-density lipoprotein particle receptor binding [IBA, ISO]
- metal chelating activity [ISO]
- phosphatidylcholine-sterol O-acyltransferase activator activity [IMP, ISO]
- phospholipid binding [IBA, ISO]
- protein binding [IPI]
- protein homodimerization activity [ISO]
- receptor binding [ISO]
- tau protein binding [ISO]
- very-low-density lipoprotein particle receptor binding [IBA, ISO]
Gene Ontology Cellular Component
- Golgi apparatus [ISO]
- blood microparticle [IBA, ISO]
- cell [IDA]
- cell surface [ISO]
- chylomicron [IBA, ISO]
- cytoplasm [ISO]
- dendrite [ISO]
- discoidal high-density lipoprotein particle [ISO]
- early endosome [ISO]
- endoplasmic reticulum [ISO]
- endosome [ISO]
- extracellular matrix [ISO]
- extracellular space [IDA, ISO]
- extracellular vesicular exosome [ISO]
- extrinsic component of external side of plasma membrane [ISO]
- high-density lipoprotein particle [IBA, ISO]
- intermediate-density lipoprotein particle [IBA, ISO]
- late endosome [ISO]
- low-density lipoprotein particle [IDA, ISO]
- lysosome [ISO]
- membrane [ISO]
- microtubule [ISO]
- neuronal cell body [ISO]
- nuclear envelope [ISO]
- nucleus [ISO]
- plasma membrane [ISO]
- very-low-density lipoprotein particle [ISO]
- vesicle [ISO]
Mus musculus
Phenotypic Enhancement
A genetic interaction is inferred when mutation or overexpression of one gene results in enhancement of any phenotype (other than lethality/growth defect) associated with mutation or over expression of another gene.
Publication
Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins.
Our previous studies have indicated that lecithin-cholesterol acyltransferase (LCAT) contributes significantly to the apoB lipoprotein cholesteryl ester (CE) pool. Cholesterol esterification rate (CER) in apoA-I(-)(/)(-) apoE(-)(/)(-) mouse plasma was <7% that of C57Bl/6 (B6) mouse plasma, even though apoA-I(-)(/)(-) apoE(-)(/)(-) plasma retained (1)/(3) the amount of B6 LCAT activity. This suggested that lack of LCAT enzyme did not explain the ... [more]
Biochemistry Jan. 25, 2005; 44(3);1013-25 [Pubmed: 15654758]
Throughput
- Low Throughput
Ontology Terms
- phenotype: abnormal circulating cholesterol level (MP:0000180)
- tissue: blood plasma (BTO:0000131)
Additional Notes
- apoA1-/- apoe-/- double mutants have much reduced LCAT activity compared to either single mutant
Related interactions
| Interaction | Experimental Evidence Code | Dataset | Throughput | Score | Curated By | Notes |
|---|---|---|---|---|---|---|
| APOE APOA1 | Co-fractionation Co-fractionation Interaction inferred from the presence of two or more protein subunits in a partially purified protein preparation. If co-fractionation is demonstrated between 3 or more proteins, then add them as a complex. | High | 0.8335 | BioGRID | 2666811 |
Curated By
- BioGRID